Snapshot from Jul 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Governments / India — National Vector Borne Disease Control Programme
Entity

India — National Vector Borne Disease Control Programme

Tracked across 1 events · 6 articles · First seen Jul 20, 2026 · Last active Jul 21, 2026

Sentiment
0
Attention
3
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
3 0
Regulatory
India approves first dengue vaccine QDENGA
India's India — Central Drugs Standard Control Organisation (CDSCO) has granted marketing authorisation for QDENGA (TAK-003), the country's first dengue vaccine, developed by Takeda Pharmaceutical Company. The vaccine is a live, attenuated tetravalent vaccine designed…
Impact: Will integrate QDENGA into existing vector control and disease surveillance efforts.
Jul 20, 2026 · 6 articles
ERGEN INTELLIGENCE
Track India — National Vector Borne Disease Control Programme live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.